BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9824118)

  • 21. Histologic features associated with long-term survival in breast cancer.
    Dawson PJ; Karrison T; Ferguson DJ
    Hum Pathol; 1986 Oct; 17(10):1015-21. PubMed ID: 3019865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Ductal Carcinoma In Situ: from the Eyes of a Beholder.
    Herschkowitz JI; Behbod F
    J Mammary Gland Biol Neoplasia; 2018 Dec; 23(4):189-190. PubMed ID: 30406903
    [No Abstract]   [Full Text] [Related]  

  • 23. Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features.
    Shiino S; Tsuda H; Yoshida M; Jimbo K; Asaga S; Hojo T; Kinoshita T
    Pathol Int; 2015 Jun; 65(6):293-300. PubMed ID: 25801805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benign epithelial proliferations in axillary lymph nodes with ipsilateral breast in situ ductal carcinoma and intraductal papilloma of the breast.
    Liu M
    Histopathology; 2008 May; 52(6):771-3. PubMed ID: 18439159
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pathological findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)].
    Haase W
    Strahlenther Onkol; 1996 Feb; 172(2):109-10. PubMed ID: 8669043
    [No Abstract]   [Full Text] [Related]  

  • 26. Tubular carcinoma of the breast and associated intra-epithelial lesions: a comparative study with invasive low-grade ductal carcinomas.
    Fernández-Aguilar S; Simon P; Buxant F; Simonart T; Noël JC
    Virchows Arch; 2005 Oct; 447(4):683-7. PubMed ID: 16091953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Breast neoplasms: histological classification].
    Sakamoto G
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():54-9. PubMed ID: 17682139
    [No Abstract]   [Full Text] [Related]  

  • 28. Ductal carcinoma in situ (intraductal carcinoma) of the breast.
    Schnitt SJ; Silen W; Sadowsky NL; Connolly JL; Harris JR
    N Engl J Med; 1988 Apr; 318(14):898-903. PubMed ID: 2832757
    [No Abstract]   [Full Text] [Related]  

  • 29. The diagnosis and management of pre-invasive breast disease--current challenges, future hopes.
    Lakhani SR
    Breast Cancer Res; 2003; 5(5):248-9. PubMed ID: 12927033
    [No Abstract]   [Full Text] [Related]  

  • 30. Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas.
    Domagala W; Woźniak L; Lasota J; Weber K; Osborn M
    Am J Pathol; 1990 Nov; 137(5):1059-64. PubMed ID: 2173410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Node status in 454 ductal breast cancers cases according to the association with in situ component].
    Carabias-Meseguer P; Cusidó-Gimferrer M; Zapardiel-Gutiérrez I; Tresserra-Casas F; Fábregas-Xauradó R; Xercavins-Montoya J
    Ginecol Obstet Mex; 2011 Jan; 79(1):5-10. PubMed ID: 21966777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of margins in invasive carcinoma and ductal carcinoma in situ: The pathologist's perspective.
    Schnitt SJ
    Breast; 2017 Aug; 34 Suppl 1():S58-S60. PubMed ID: 28663004
    [No Abstract]   [Full Text] [Related]  

  • 33. [Management of ductal carcinoma in situ by the pathologist: current questions].
    Arnould L; Caron Y; Sigal-Zafrani B
    Ann Pathol; 2003 Dec; 23(6):534-46. PubMed ID: 15094591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A histochemical and ultrastructural study of human breast carcinomas with a view to their classification by cell of origin.
    Bencosme SA; Raymond MJ; Ross RC; Mobbs B; Tsutsumi V; Ortiz H; Gonzalez R; Segura E
    Exp Mol Pathol; 1979 Aug; 31(1):236-47. PubMed ID: 222604
    [No Abstract]   [Full Text] [Related]  

  • 35. Ductal carcinoma in-situ of the breast; second EORTC consensus meeting.
    van Dongen JA; Holland R; Peterse JL; Fentiman IS; Lagios MD; Millis RR; Recht A
    Eur J Cancer; 1992; 28(2-3):626-9. PubMed ID: 1317200
    [No Abstract]   [Full Text] [Related]  

  • 36. The selective use of sentinel node biopsy in ductal carcinoma in situ.
    Bleicher RJ; Giuliano AE
    Arch Surg; 2003 May; 138(5):489. PubMed ID: 12742950
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathological classification of DCIS and planning of therapeutic management.
    Buonomo O; Orsaria P; Contino G; Varvaras D; Gioia A; Bonanno E; Pistolese C; Cossu E; Perretta T; Schillaci O; Del Monte G; Roselli M; Mineo TC; Petrella G
    Anticancer Res; 2009 May; 29(5):1499-506. PubMed ID: 19443357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ductal Carcinoma In Situ Stage 0 Breast Cancer: When Less May Be Better.
    Harris JV
    JAMA Intern Med; 2016 Jul; 176(7):887. PubMed ID: 27244094
    [No Abstract]   [Full Text] [Related]  

  • 39. Clear cell variant of ductal carcinoma in situ of the breast.
    Terada T
    Breast J; 2012; 18(3):279-80. PubMed ID: 22530727
    [No Abstract]   [Full Text] [Related]  

  • 40. Multicentric adenomyoepithelioma of the breast with atypia and associated ductal carcinoma in situ.
    Han JS; Peng Y
    Breast J; 2010; 16(5):547-9. PubMed ID: 20604795
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.